Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $46 at Mizuho

December 1, 2025 5:48 AM EST Send to a Friend
Mizuho analyst Graig Suvannavejh raised the price target on Harmony Biosciences Holdings Inc. (NASDAQ: HRMY) to $46.00 (from $39.00) while ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login